Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Registration opens for next VMG Congress
Dr Andy Cope will deliver the keynote speech.

Wellbeing specialist will give the keynote speech.

Veterinary Management Group (VMG) has opened registration for VMG Congress 2024, which will be held at Stratford-upon-Avon on 25-26 April 2024.

Dr Andy Cope, a mental health and wellbeing expert, will be the keynote speaker.

VMG director Liz Somerville said: “Building on the success of our 2023 Congress, VMG is committed to giving our delegates access to vibrant and innovative speakers, who offer relevant content to support them in their goals as leaders, managers and business owners.”

Full details of the programme can be found on the VMG website.

 

Andy Cope image (C) Karina Lebrun / Liz Somerville image (C) VMG

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.